Astec Lifesciences (NSE:ASTEC) Net Income (Continuing Operations): ₹-666 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
66 GF Score
Price ₹554.45
GF Value ₹920.89
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Net Income (Continuing Operations)?

Astec Lifesciences NSE:ASTEC -3.28% 66 Net Income (Continuing Operations) is ₹-666 Mil as of Jun. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 66/100 and a GF Value™ of ₹920.89 (Possible Value Trap). The stock has 4 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Astec Lifesciences's Net Income (Continuing Operations) for the three months ended in Jun. 2026 was ₹-187 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-666 Mil.

Astec Lifesciences  (NSE:ASTEC) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Astec Lifesciences Net Income (Continuing Operations) Related Terms

Astec Lifesciences Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Net Income (Continuing Operations) Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 898.83 255.94 -468.91 -1,347.12 -808.76

Astec Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -330.27 -244.17 -156.85 -77.47 -187.07
NSE:ASTEC
66GF Score
Astec Lifesciences Ltd NSE:ASTEC
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-666 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of ₹-666 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a Net Income (Continuing Operations) of ₹-666 Mil as of Jun. 2026. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' Net Income (Continuing Operations) too high?
Astec Lifesciences' current Net Income (Continuing Operations) is ₹-666 Mil. Overall, Astec Lifesciences has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Net Income (Continuing Operations) compare to CTVA and CF?
Astec Lifesciences' Net Income (Continuing Operations) of ₹-666 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for an Agriculture company?
A good Net Income (Continuing Operations) depends on the Agriculture industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current Net Income (Continuing Operations) is ₹-666 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Possible Value Trap. The stock's GF Value™ is ₹920.89, compared to a current price of ₹554.45 — trading 39.8% below its estimated fair value. The current Net Income (Continuing Operations) is ₹-666 Mil. Astec Lifesciences' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Net Income (Continuing Operations) is ₹-666 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹554.45 is trading 39.8% below its estimated GF Value™ of ₹920.89. GuruFocus considers Astec Lifesciences to be Possible Value Trap.

Key valuation signals for NSE:ASTEC:

  • Net Income (Continuing Operations): ₹-666 Mil
  • GF Value™: ₹920.89 vs. price of ₹554.45 (39.8% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
66GF Score

Get the complete analysis for NSE:ASTEC

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹554.45
Price
₹920.89
GF Value